B Cell Depletion with Rituximab in Graves' Disease and Associated Orbitopathy

E-ISSN： 1875-6115|11|2|99-111

ISSN： 1871-5222

Source： Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol.11, Iss.2, 2011-06, pp. : 99-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pathogenesis of Graves' Orbitopathy

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 11, Iss. 2, 2011-06 ,pp. : 72-82

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Spectrum of Graves' Orbitopathy

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 11, Iss. 2, 2011-06 ,pp. : 83-89

Bentham Science Publishers

Access to resources Recommend Favorite

Steroids and the Immune Response in Graves' Orbitopathy

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 11, Iss. 2, 2011-06 ,pp. : 90-98

Bentham Science Publishers

Access to resources Recommend Favorite

B-Cell Depletion in Wegener’s Granulomatosis

By Hinze Claas Colbert Robert

Clinical Reviews in Allergy and Immunology, Vol. 34, Iss. 3, 2008-06 ,pp. : 372-379

Humana Press, Inc

Access to resources Recommend Favorite

Rituximab in the treatment of diffuse large B-cell lymphoma primary of the lung

By Aviles Agustin Nambo Maria J. Huerta-Guzman Judith Silva Luis Neri Natividad

Hematology, Vol. 18, Iss. 2, 2013-03 ,pp. : 81-84

Maney Publishing

Access to resources Recommend Favorite